GlassScriptPhysician profile
Maulik K Bhalani
NPI 1336331008
$20,401.17
in general payments reported to CMS, 2019-2025
40 companies · $2,053 in 2025
The $2,053 reported for 2025 was more than what 79% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,687 · 2020: $934 · 2021: $2,193 · 2022: $3,932 · 2023: $1,901 · 2024: $7,702 · 2025: $2,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,686 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,400 · Travel and Lodging: $2,515 · Education: $32.08 · Entertainment: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,685.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,400.00 |
| Travel and Lodging | $2,514.74 |
| Education | $32.08 |
| Entertainment | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,069.43 | 2021-2025 | Intellis Adaptivestim |
| Abbott Laboratories | $3,435.90 | 2019-2025 | Proclaim, Axium |
| Boston Scientific Corporation | $2,494.61 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Stimwave Technologies Incorporated | $562.14 | 2019-2022 | |
| Medtronic USA, INC. | $546.93 | 2019-2020 | |
| Relievant Medsystems, INC. | $471.70 | 2021-2023 | Intracept |
| Nevro Corp. | $439.80 | 2019-2024 | Senza |
| Foundation Fusion Solutions, LLC | $281.44 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $268.50 | 2019-2020 | |
| Amgen INC. | $219.27 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.18 | 2020-2025 | Relistor |
| Spr Therapeutics, INC | $160.19 | 2025 | Sprint Pns System |
| Tersera Therapeutics LLC | $126.27 | 2019-2021 | |
| Painteq LLC | $125.33 | 2024 | Painteq |
| Astrazeneca Pharmaceuticals LP | $101.68 | 2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maulik Bhalani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.